EXAGEN INC. Public Float
EXAGEN INC. (XGN) had Public Float of $153.60 million as of 2025-06-30, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-10
- 2025-06-30: Entity Public Float $153.60M.
- 2024-06-30: Entity Public Float $27.00M.
- 2023-06-30: Entity Public Float $37.30M.
- 2022-06-30: Entity Public Float $61.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $153.60M 10-K · filed 2026-03-10 |
| 2024-06-30 | $27.00M 10-K · filed 2025-03-11 |
| 2023-06-30 | $37.30M 10-K · filed 2024-03-18 |
| 2022-06-30 | $61.50M 10-K · filed 2023-03-20 |
| 2021-06-30 | $158.30M 10-K · filed 2022-03-22 |
| 2020-06-30 | $83.40M 10-K/A · filed 2021-04-01 |
| 2019-09-30 | $104.90M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |